Does ADALIMUMAB Cause Hodgkin's disease? 225 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 225 reports of Hodgkin's disease have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
225
Reports of Hodgkin's disease with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
14
Deaths
77
Hospitalizations
How Dangerous Is Hodgkin's disease From ADALIMUMAB?
Of the 225 reports, 14 (6.2%) resulted in death, 77 (34.2%) required hospitalization, and 47 (20.9%) were considered life-threatening.
Is Hodgkin's disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 225 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Hodgkin's disease?
BRENTUXIMAB VEDOTIN (512)
METHOTREXATE (347)
DOXORUBICIN (298)
CYCLOPHOSPHAMIDE (223)
INFLIXIMAB (209)
VINCRISTINE (193)
PREDNISOLONE (179)
RITUXIMAB (170)
VINBLASTINE (165)
ETOPOSIDE (157)
Which ADALIMUMAB Alternatives Have Lower Hodgkin's disease Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB